Certara stock.

Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its …Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Certara, Inc.'s business for stockholders, potential investors, and financial analysts.Patrick Smith CERT stock SEC Form 4 insiders trading. Patrick has made over 6 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Patrick sold 19,104 units of CERT stock worth $411,691 on 5 June 2023.19,104 units of CERT stock worth $411,691 on 5 June 2023.OPGN | Complete OpGen Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Nov 30, 2023 · Stock analysis for Certara Inc (CERT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Certara Inc’s stock is NA in 2023, NA in the previous five trading days and down 2.67% in the past year. Currently, Certara Inc does not have a price-earnings ratio. Certara Inc’s trailing 12-month revenue is $353.0 million with a -9.6% net profit margin. Year-over-year quarterly sales growth most recently was 1.1%.Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

Certara Stock Price, News & Analysis (NASDAQ:CERT) $14.64 +0.23 (+1.60%) (As of 12/1/2023 ET) Compare Today's Range $14.12 $14.67 50-Day Range …

View the latest Certara Inc. (CERT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Shares of Certara, Inc. (NASDAQ:CERT – Get Free Report) have earned an average recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 …Certara share price went down by -16.68% last month. The next quarterly earnings date for Certara is scheduled on November 7, 2023. Certara's next ex-dividend date is August 20, 2023.0.68%. $788.96M. Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full …

Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screens

The institutional investor owned 3,910,996 shares of the company's stock after buying an additional 346,460 shares during the quarter. JPMorgan Chase & Co. owned about 2.45% of Certara worth $84,008,000 at the end of the most recent reporting period. A number of other hedge funds have also added to or reduced their stakes in the stock.

ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ...Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free RegistrationPRINCETON, N.J., November 17, 2021. — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public …OPKO Health Inc. 1.53. +0.07. +4.79%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Nov 28, 2023 · CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth. Certara, which supplies biosimulation software for customers, undermined investor confidence when it sold 10 million shares for $31. Conversely, Schrödinger made inducement grants of only 7,250 ...

Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ... Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ...According to 7 stock analysts, the average 12-month stock price forecast for Certara stock is $50.29, which predicts an increase of 240.60%. The lowest target is $16 and the highest is $235. On average, analysts rate Certara stock as a buy.Share WA. Call · Chat WA · Facebook Twitter Youtube. Tanyakan tentang properti ini. Halo, saya tertarik dengan [RUMAH Cluster Certara Park Citra Raya – Cikupa].

The estimated Net Worth of William F Feehery is at least $64.1 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $30,975,471 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Find the latest Udemy, Inc. (UDMY) stock quote, history, news and other vital information to help you with your stock trading and investing.

Nov 21, 2023 · About Certara Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at Certara.com. Certara Contact: Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools …CERT Certara, Inc. Stock Price & Overview 2.67K followers $14.64 0.23 ( +1.60%) 4:00 PM 12/01/23 NASDAQ | $USD | Post-Market: $14.64 4:03 PM Summary …John Gallagher CERT stock SEC Form 4 insiders trading. John has made over 9 trades of the Certara stock since 2015, according to the Form 4 filled with the SEC. Most recently John exercised 5,746 units of CERT stock worth $437,730 on 27 February 2018.5,746 units of CERT stock worth $437,730 on 27 February 2018.The average twelve-month price prediction for Air Products and Chemicals is $320.31 with a high price target of $360.00 and a low price target of $240.00. Learn more on APD's analyst rating history. Do Wall Street analysts like Air Products and Chemicals more than its competitors?Drayton Virkler CERT stock SEC Form 4 insiders trading. Drayton has made over 2 trades of the Certara stock since 2022, according to the Form 4 filled with the SEC. Most recently Drayton exercised 3,990 units of CERT stock worth $57,536 on 31 March 2023.3,990 units of CERT stock worth $57,536 on 31 March 2023.The company had revenue of $85.58 million for the quarter, compared to analyst estimates of $85.96 million. Certara has generated ($0.21) earnings per share over the last year (($0.21) diluted earnings per share). Earnings for Certara are expected to decrease by -9.09% in the coming year, from $0.33 to $0.30 per share.

Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.

The estimated Net Worth of William F Feehery is at least $68.6 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $35,387,994 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.

Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf ... - Certara - Investor Tools. Print Page. Email Alerts ...Real time Certara (CERT) stock price quote, stock graph, news & analysis. Nov 30, 2023 · Stock analysis for Certara Inc (CERT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. A high-level overview of Twilio Inc. (TWLO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Find the latest Udemy, Inc. (UDMY) stock quote, history, news and other vital information to help you with your stock trading and investing.We would like to show you a description here but the site won’t allow us.Find the latest TETRA Technologies, Inc. (TTI) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 21, 2023 · Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.

CERT Certara, Inc. Stock Price & Overview 2.67K followers $14.64 0.23 ( +1.60%) 4:00 PM 12/01/23 NASDAQ | $USD | Post-Market: $14.64 4:03 PM Summary …Dec 1, 2023 · Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT. With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ...William Blair Investment Management LLC grew its position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) by 4.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,026,786 shares of the company's sInstagram:https://instagram. forex brokers accepting us clientsbhp stokstla stock dividendfundrise review 2023 Frontage Holdings Corp. -0.47%. HK$4.39B. CERT | Complete Certara Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. bazinga newsalfa romeo quad Certara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability … nasdaq arcc Those who successfully complete the certification courses will earn the following certifications: Certara Certified NCA Analyst using Phoenix WinNonlin Version 8.3 Certara Certified PK/PD Modeler using Phoenix WinNonlin 8.4 This bundle includes four courses: two conceptual courses (delivered in e-learning format) and two certification courses ...Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT.